These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7859389)

  • 1. Protective role of bradykinin in cardiac anaphylaxis. Coronary-vasodilating and antiarrhythmic activities mediated by autocrine/paracrine mechanisms.
    Rubin LE; Levi R
    Circ Res; 1995 Mar; 76(3):434-40. PubMed ID: 7859389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.
    Giannella E; Mochmann HC; Levi R
    Circ Res; 1997 Sep; 81(3):415-22. PubMed ID: 9285644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
    Vegh A; Papp JG; Parratt J
    Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH; Busse R
    Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: effects of inhibition of NO-synthesis and captopril.
    Zanzinger J; Bassenge E
    Eur Heart J; 1993 Nov; 14 Suppl I():164-8. PubMed ID: 8293769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Zanzinger J; Zheng X; Bassenge E
    Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts.
    Hatta E; Maruyama R; Marshall SJ; Imamura M; Levi R
    J Pharmacol Exp Ther; 1999 Mar; 288(3):919-27. PubMed ID: 10027827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
    Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
    Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis.
    Juan H; Peskar BA; Simmet T
    Br J Pharmacol; 1987 Feb; 90(2):315-25. PubMed ID: 2881590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endogenous bradykinin in human coronary vasomotor control.
    Groves P; Kurz S; Just H; Drexler H
    Circulation; 1995 Dec; 92(12):3424-30. PubMed ID: 8521563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of responses to bradykinin: effects of Hoe-140 in the hindquarters vascular bed of the cat.
    Santiago JA; Garrison EA; Kadowitz PJ
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H828-36. PubMed ID: 8067439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.
    Kaszala K; Végh A; Papp JG; Parratt JR
    Eur J Pharmacol; 1997 Jun; 328(1):51-60. PubMed ID: 9203568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Anning PB; Grocott-Mason RM; Lewis MJ
    Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.